tirzepatide in oral form tirzepatide: what actually exists, what does not, and what is coming next Ready to kick start your

Semaglutide and similar GLP-1-based medications have shown impressive results and bring hope to many people who struggle to shed extra pounds

The medication is administered subcutaneously once weekly and reaches steady-state concentrations after 45 weeks of treatment, according to the Wegovy Summary of Product Characteristics (SmPC)

A large cross-sectional analysis demonstrated impaired semen quality among men with metabolic syndrome, characterised by reduced normal morphology and sperm progressive motility

And you developed a qualifying injury that required medical treatment or hospitalization

If you suspect you are experiencing a side effect from Wegovy, you can report this through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)